Topic: Antiretroviral Treatment
Antiretroviral treatment that results in full viral load suppression is clinically beneficial (making it possible to manage HIV as a chronic condition) and significantly reduces the risk of HIV transmission. Federal expert panels now recommend early treatment for anyone living with HIV, and though there are relatively simple regimens available, patients must adhere to them for a lifetime. Monitoring and managing treatment success is a complex task for clinicians. Finally, despite the many advances in recent years, there is still much that is not understood about the long term impact of HIV and HIV medications.
Filter resources by:
Guidelines and Manuals
U.S. Department of Health and Human ServicesDecember 2014
Federal guidelines for treatment of HIV/AIDS and related conditions and for prevention-related topics such as perinatal transmission, workplace exposures, non-occupational exposures, routine HIV testing, and others.
HRSA HIV/AIDS BureauDecember 2014
Guidance for Ryan White HIV/AIDS Program grantees and planning bodies on the development and implementation of local service standards.
HRSA HIV/AIDS BureauApril 2014
This manual was developed to provide clinicians with ready access to practical, current, treatment information so that they may provide quality care to people living with HIV.
HRSA HIV/AIDS BureauNovember 2013Performance measures to help Ryan White HIV/AIDS programs monitor and improve the quality of care they deliver.
Webinars and Training
AETC National Resource CenterJanuary 2014
Clinical education/training resources and patient education materials from the HRSA AETC network.
Philadelphia Office of HIV PlanningNovember 2012
This interactive InfoGraphic explains the Treatment Cascade--a visual model that shows how the proportion of individuals living with HIV/AIDS with fully suppressed virus (i.e., those fully benefiting from HIV/AIDS therapy) cascades downward due to factors like not knowing one's HIV status or being in care inconsistently or not at all.
Overview of the 340B program and its relationship to ADAP. See also HRSA's 340 Drug Pricing Program webpage.
HRSA HIV/AIDS BureauAugust 2010
Clinical debate of the mathematical theory that HIV/AIDS can be eliminated from society if all adults are tested regularly and all infected persons are put on antiretroviral therapy—regardless of CD4 level.
HRSA HIV/AIDS BureauJune 2010
Overview of HIV drug resistance, its role in transmitting resistant HIV virus, and what clients and peers need to know about it. The webcast also includes an overview of the role of HIV biomedical interventions in reducing risk of HIV transmission.
Tools and Job Aids
The Common Patient Assistance Program (PAP) Application can be used to apply for any pharmaceutical assistance program (PAP) offered by pharmaceutical companies.
El Rio Community Health CenterJanuary 2004
One-pager poses question to client, "How Ready are You for the Challenge of Taking Your HIV Medications Everyday" followed by scale for patient to mark where they self-assess their readiness.
Reports and Best Practices
New Mexico AETC and International Association of Providers of AIDS Care (IAPAC)January 2012
AIDS InfoNet provides reliable, non-technical HIV/AIDS treatment information in English, Spanish, and other languages. The primary audience for InfoNet materials includes people living with HIV and their caregivers, especially nurses and other first-line treatment providers.
New York State Department of Health AIDS InstituteJanuary 2015
HIV guidelines, quality of care, clinical education, resources, policies and publications.
U.S. Department of Health and Human ServicesAugust 2014
AIDSinfo is the official home to all U.S. HIV-related treatment guidelines. The site also includes a HIV/AIDS health topics database and fact sheets on FDA-approved and investigational HIV/AIDS-related drugs, educational materials for consumers and providers, and a clinical trials database.
AETC National Resource CenterJanuary 2014
Clinician training resources and tools such as pocket guides, wall charts, and patient education fact sheets developed by the HRSA AIDS Education and Training Centers network. Includes comprehensive training slides to accompany HHS guidelines.
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
U.S. Department of Health and Human Services (DHHS)January 2012
infoSIDA ofrece acceso a información actualizada en español sobre el tratamiento de la infección por el VIH/SIDA y ensayos clínicos desarrollados específicamente para las comunidades afectadas por dicha infección y para otras comunidades de atención de salud.